Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.86 billion. The enterprise value is $2.03 billion.
| Market Cap | 1.86B |
| Enterprise Value | 2.03B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 105.63 million shares outstanding. The number of shares has increased by 7.47% in one year.
| Current Share Class | 105.63M |
| Shares Outstanding | 105.63M |
| Shares Change (YoY) | +7.47% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 4.78% |
| Owned by Institutions (%) | 102.79% |
| Float | 100.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 77.81 |
| PS Ratio | 0.95 |
| Forward PS | 1.32 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | 10.52 |
| P/OCF Ratio | 10.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.46, with an EV/FCF ratio of 11.51.
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | 85.46 |
| EV / EBIT | n/a |
| EV / FCF | 11.51 |
Financial Position
The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.69.
| Current Ratio | 3.46 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 5.21 |
| Debt / FCF | 5.97 |
| Interest Coverage | -0.22 |
Financial Efficiency
Return on equity (ROE) is -8.05% and return on invested capital (ROIC) is -0.48%.
| Return on Equity (ROE) | -8.05% |
| Return on Assets (ROA) | -0.16% |
| Return on Invested Capital (ROIC) | -0.48% |
| Return on Capital Employed (ROCE) | -0.33% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | $2.34M |
| Profits Per Employee | -$137,267 |
| Employee Count | 835 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.42 |
Taxes
In the past 12 months, SRPT has paid $22.60 million in taxes.
| Income Tax | 22.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.46% in the last 52 weeks. The beta is 0.45, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +8.46% |
| 50-Day Moving Average | 19.20 |
| 200-Day Moving Average | 18.67 |
| Relative Strength Index (RSI) | 44.25 |
| Average Volume (20 Days) | 2,510,071 |
Short Selling Information
The latest short interest is 22.33 million, so 21.14% of the outstanding shares have been sold short.
| Short Interest | 22.33M |
| Short Previous Month | 22.78M |
| Short % of Shares Out | 21.14% |
| Short % of Float | 22.21% |
| Short Ratio (days to cover) | 7.84 |
Income Statement
In the last 12 months, SRPT had revenue of $1.96 billion and -$114.62 million in losses. Loss per share was -$1.09.
| Revenue | 1.96B |
| Gross Profit | -411.10M |
| Operating Income | -8.40M |
| Pretax Income | -92.02M |
| Net Income | -114.62M |
| EBITDA | 23.76M |
| EBIT | -8.40M |
| Loss Per Share | -$1.09 |
Balance Sheet
The company has $878.78 million in cash and $1.05 billion in debt, with a net cash position of -$174.25 million or -$1.65 per share.
| Cash & Cash Equivalents | 878.78M |
| Total Debt | 1.05B |
| Net Cash | -174.25M |
| Net Cash Per Share | -$1.65 |
| Equity (Book Value) | 1.53B |
| Book Value Per Share | 14.26 |
| Working Capital | 1.62B |
Cash Flow
In the last 12 months, operating cash flow was $185.56 million and capital expenditures -$9.16 million, giving a free cash flow of $176.40 million.
| Operating Cash Flow | 185.56M |
| Capital Expenditures | -9.16M |
| Depreciation & Amortization | 32.16M |
| Net Borrowing | -35.13M |
| Free Cash Flow | 176.40M |
| FCF Per Share | $1.67 |
Margins
Gross margin is -21.01%, with operating and profit margins of -0.43% and -5.86%.
| Gross Margin | -21.01% |
| Operating Margin | -0.43% |
| Pretax Margin | -4.70% |
| Profit Margin | -5.86% |
| EBITDA Margin | 1.21% |
| EBIT Margin | -0.43% |
| FCF Margin | 9.02% |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.47% |
| Shareholder Yield | -7.47% |
| Earnings Yield | -6.20% |
| FCF Yield | 9.50% |
Analyst Forecast
The average price target for SRPT is $21.64, which is 23.16% higher than the current price. The consensus rating is "Hold".
| Price Target | $21.64 |
| Price Target Difference | 23.16% |
| Analyst Consensus | Hold |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | -16.16% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |